Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-12.22	15.24	17.36
Graham Fair Price	15.67	34.71	30.01
PEG	590.80	0.51	0.07
Price/Book	-4.06	1.52	1.59
Price/Cash Flow	-8.32	-57.06	62.23
Prices/Earnings	4.97	3.76	3.58
Price/Sales	3.90	7.08	6.81
Price/FCF	-8.32	-57.06	62.23
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.53	0.65	0.59
Operating Margin	-0.43	0.50	0.50
ROA	-7.26	0.06	0.06
ROE	0.11	0.10	-8.60
ROIC	0.07	0.07	-8.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.23	-0.03	789.12
Dividends QOQ	-0.06	-1.00	-1497.11
EBIT QOQ	0.40	0.14	-64.48
EPS QOQ	0.48	0.07	-84.80
FCF QOQ	-0.76	-2.30	-201.28
Revenue QOQ	0.08	0.15	75.11
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	34.79	40.77	17.19
Days Sales Outstanding (DSO)	50.83	65.28	28.43
Inventory Turnover	2.59	2.21	-14.67
Debt/Capitalization	0.39	0.39	-0.38
Quick Ratio	1.82	3.47	90.00
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18.99	22.98	20.99
Cash	3.03	6.65	119.41
Capex	-1.74	-2.69	-54.63
Free Cash Flow	0.48	-0.61	26.61
Revenue	4.43	4.95	11.72
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.60	3.63	39.34
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.01	2.92	-27.13
Naive Interpretation	Member

06 - Financial Health · Bad

Rating